tiprankstipranks
Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
US Market

Centessa Pharmaceuticals (CNTA) Income Statement

Compare
145 Followers

Centessa Pharmaceuticals Income Statement

Last quarter (Q3 2024), Centessa Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Centessa Pharmaceuticals's net income was $-42.57M. See Centessa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.85M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 6.85M$ -130.92K$ -33.99K$ 0.00
Operating Expenses
$ 178.14M$ 210.28M$ 139.28M$ 10.44M
Depreciation and Amortization
$ 813.14K$ 130.92K$ 33.99K$ 6.00K
EBITDA
$ -166.07M$ -212.26M$ -379.16M$ -10.43M
Operating Income
$ -171.28M$ -212.26M$ -139.31M$ -10.44M
Other Income/Expenses
$ -4.86M$ -4.69M$ -6.87M$ -223.00K
Pretax Income
$ -176.14M$ -216.95M$ -381.74M$ -10.66M
Net Income
$ -151.09M$ -216.21M$ -381.85M$ -11.04M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.57$ -2.31$ -4.24$ -0.08
Diluted EPS
$ -1.57$ -2.31$ -4.24$ -0.08
Weighted Average Shares Outstanding
96.18M 93.40M 89.99M 142.06M
Weighted Average Shares Outstanding (Diluted)
96.18M 93.40M 89.99M 142.06M
Currency in USD

Centessa Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis